Published in Neuropsychopharmacology on September 12, 2007
Racial disparities in methamphetamine-associated intracerebral hemorrhage. Neurology (2015) 1.63
Is cognitive functioning impaired in methamphetamine users? A critical review. Neuropsychopharmacology (2011) 1.21
An evaluation of the evidence that methamphetamine abuse causes cognitive decline in humans. Neuropsychopharmacology (2012) 1.09
Residual effects of intranasal methamphetamine on sleep, mood, and performance. Drug Alcohol Depend (2007) 1.07
Comparison of intranasal methamphetamine and d-amphetamine self-administration by humans. Addiction (2012) 1.00
Methamphetamine-associated cardiomyopathy. Clin Cardiol (2013) 0.99
Amphetamine analogs methamphetamine and 3,4-methylenedioxymethamphetamine (MDMA) differentially affect speech. Psychopharmacology (Berl) (2009) 0.95
Extinction-dependent alterations in corticostriatal mGluR2/3 and mGluR7 receptors following chronic methamphetamine self-administration in rats. PLoS One (2012) 0.91
Effects of MDMA, methamphetamine and methylphenidate on repeated acquisition and performance in rats. Pharmacol Biochem Behav (2009) 0.90
Investigation of "bath salts" use patterns within an online sample of users in the United States. J Psychoactive Drugs (2014) 0.90
MDMA and methamphetamine: some paradoxical negative and positive mood changes in an acute dose laboratory study. Psychopharmacology (Berl) (2011) 0.87
Subjective and physiological effects of acute intranasal methamphetamine during d-amphetamine maintenance. Psychopharmacology (Berl) (2010) 0.87
Comparison of the behavioral and cardiovascular effects of intranasal and oral d-amphetamine in healthy human subjects. J Clin Pharmacol (2010) 0.86
The effects of progesterone pretreatment on the response to oral d-amphetamine in Women. Horm Behav (2010) 0.86
Effects of intranasal methamphetamine on metacognition of agency. Psychopharmacology (Berl) (2007) 0.85
A novel strategy for dissecting goal-directed action and arousal components of motivated behavior with a progressive hold-down task. Behav Neurosci (2015) 0.85
Naltrexone and bupropion, alone or combined, do not alter the reinforcing effects of intranasal methamphetamine. Pharmacol Biochem Behav (2014) 0.84
Methamphetamine self-administration in humans during D-amphetamine maintenance. J Clin Psychopharmacol (2014) 0.84
The Effects of Naltrexone on Subjective Response to Methamphetamine in a Clinical Sample: a Double-Blind, Placebo-Controlled Laboratory Study. Neuropsychopharmacology (2015) 0.83
Alternative reinforcer response cost impacts methamphetamine choice in humans. Pharmacol Biochem Behav (2012) 0.80
Simultaneous thrombosis of the left anterior descending artery and the right coronary artery in a 34-year-old crystal methamphetamine abuser. Korean Circ J (2015) 0.80
Physiological and subjective effects of acute intranasal methamphetamine during atomoxetine maintenance. Pharmacol Biochem Behav (2011) 0.79
Repeated Acquisition in the Morris Swim Task: Effects of MDMA, Methamphetamine and Methylphenidate. Psychol Rec (2014) 0.78
The acute effects of 3,4-methylenedioxymethamphetamine and d-methamphetamine on human cognitive functioning. Psychopharmacology (Berl) (2011) 0.78
Impact of methamphetamine on infection and immunity. Front Neurosci (2015) 0.78
Boundary conditions of methamphetamine craving. Exp Clin Psychopharmacol (2015) 0.76
A Markerless 3D Computerized Motion Capture System Incorporating a Skeleton Model for Monkeys. PLoS One (2016) 0.75
Voluntary inhalation of methamphetamine: a novel strategy for studying intake non-invasively. Psychopharmacology (Berl) (2016) 0.75
Crack cocaine and cocaine hydrochloride. Are the differences myth or reality? JAMA (1996) 1.95
Bupropion reduces methamphetamine-induced subjective effects and cue-induced craving. Neuropsychopharmacology (2005) 1.65
Pharmacokinetics of methamphetamine self-administered to human subjects by smoking S-(+)-methamphetamine hydrochloride. Drug Metab Dispos (1993) 1.61
Effects of acute smoked marijuana on complex cognitive performance. Neuropsychopharmacology (2001) 1.53
Methamphetamine self-administration by humans. Psychopharmacology (Berl) (2001) 1.40
Relevance of pharmacokinetic parameters in animal models of methamphetamine abuse. Synapse (2001) 1.40
Reinforcing effects of modafinil: influence of dose and behavioral demands following drug administration. Psychopharmacology (Berl) (2005) 1.39
Effects of smoking on rapid information processing performance. Neuropsychobiology (1983) 1.38
Choice between money and intranasal heroin in morphine-maintained humans. Behav Pharmacol (1997) 1.29
Methamphetamine and ethanol interactions in humans. Clin Pharmacol Ther (1995) 1.28
The bioavailability of intranasal and smoked methamphetamine. Clin Pharmacol Ther (2003) 1.28
The acute effects of d-amphetamine and methamphetamine on attention and psychomotor performance. Psychopharmacology (Berl) (2006) 1.20
Performance-based testing for drugs of abuse: dose and time profiles of marijuana, amphetamine, alcohol, and diazepam. J Anal Toxicol (1993) 1.09
Reinforcing effects of methylphenidate: influence of dose and behavioral demands following drug administration. Psychopharmacology (Berl) (2004) 1.08
A comparison of assessment techniques measuring the effects of methylphenidate, secobarbital, diazepam and diphenhydramine in abstinent alcoholics. Neuropsychobiology (1988) 1.05
Effects of repeated oral methamphetamine administration in humans. Psychopharmacology (Berl) (2001) 1.05
A comparison of injecting and noninjecting methamphetamine users. J Psychoactive Drugs (2000) 1.00
Effects of the NMDA antagonist memantine on human methamphetamine discrimination. Psychopharmacology (Berl) (2002) 0.98
Effects of isradipine, a dihydropyridine-class calcium channel antagonist, on D-methamphetamine-induced cognitive and physiological changes in humans. Neuropsychopharmacology (2000) 0.95
Modafinil attenuates disruptions in cognitive performance during simulated night-shift work. Neuropsychopharmacology (2005) 0.93
Isradipine, a dihydropyridine-class calcium channel antagonist, attenuates some of d-methamphetamine's positive subjective effects: a preliminary study. Psychopharmacology (Berl) (1999) 0.93
Effects of isradipine on methamphetamine-induced changes in attentional and perceptual-motor skills of cognition. Psychopharmacology (Berl) (2004) 0.93
Intranasal cocaine in humans: acute tolerance, cardiovascular and subjective effects. Pharmacol Biochem Behav (2004) 0.93
Repeated intranasal cocaine administration: lack of tolerance to pressor effects. Drug Alcohol Depend (1988) 0.93
A comprehensive assessment of the safety of intravenous methamphetamine administration during treatment with selegiline. Pharmacol Biochem Behav (2006) 0.92
Amphetamine self-administration by humans: modulation by contingencies associated with task performance. Psychopharmacology (Berl) (1996) 0.92
Methamphetamine effects on cognitive processing during extended wakefulness. Int J Aviat Psychol (1996) 0.91
Combined effects of methamphetamine and zolpidem on performance and mood during simulated night shift work. Pharmacol Biochem Behav (2005) 0.91
Modulation of drug reinforcement by behavioral requirements following drug ingestion. Psychopharmacology (Berl) (1994) 0.90
Methamphetamine attenuates disruptions in performance and mood during simulated night-shift work. Psychopharmacology (Berl) (2003) 0.87
Is craving mood-driven or self-propelled? Sensitization and "street" stimulant addiction. NIDA Res Monogr (1996) 0.86
Reinforcing effects of oral cocaine: contextual determinants. Psychopharmacology (Berl) (2001) 0.85
Enhancing caffeine reinforcement by behavioral requirements following drug ingestion. Psychopharmacology (Berl) (1994) 0.85
Effects of isradipine, a dihydropyridine-class calcium-channel antagonist, on d-methamphetamine's subjective and reinforcing effects. Int J Neuropsychopharmacol (2005) 0.85
Amphetamine-induced dopamine release: markedly blunted in cocaine dependence and predictive of the choice to self-administer cocaine. Am J Psychiatry (2007) 2.90
Abuse liability measures for use in analgesic clinical trials in patients with pain: IMMPACT recommendations. Pain (2013) 2.58
Alcohol dependence is associated with blunted dopamine transmission in the ventral striatum. Biol Psychiatry (2005) 2.45
Cocaine dependence and d2 receptor availability in the functional subdivisions of the striatum: relationship with cocaine-seeking behavior. Neuropsychopharmacology (2004) 2.24
Marijuana withdrawal in humans: effects of oral THC or divalproex. Neuropsychopharmacology (2004) 2.09
The effects of smoked cocaine during the follicular and luteal phases of the menstrual cycle in women. Psychopharmacology (Berl) (2001) 2.02
Smoked cocaine self-administration is decreased by modafinil. Neuropsychopharmacology (2007) 1.97
Classification and definition of misuse, abuse, and related events in clinical trials: ACTTION systematic review and recommendations. Pain (2013) 1.89
Polydrug abuse: a review of opioid and benzodiazepine combination use. Drug Alcohol Depend (2012) 1.85
Cocaine-specific antibodies blunt the subjective effects of smoked cocaine in humans. Biol Psychiatry (2010) 1.75
Explaining the escalation of drug use in substance dependence: models and appropriate animal laboratory tests. Pharmacology (2007) 1.62
Exogenous progesterone attenuates the subjective effects of smoked cocaine in women, but not in men. Neuropsychopharmacology (2006) 1.56
Effects of THC and lofexidine in a human laboratory model of marijuana withdrawal and relapse. Psychopharmacology (Berl) (2007) 1.53
Challenges in the development of prescription opioid abuse-deterrent formulations. Clin J Pain (2007) 1.48
Comparison of smoked marijuana and oral Delta(9)-tetrahydrocannabinol in humans. Psychopharmacology (Berl) (2002) 1.47
Dronabinol and marijuana in HIV-positive marijuana smokers. Caloric intake, mood, and sleep. J Acquir Immune Defic Syndr (2007) 1.44
Does the response to cocaine differ as a function of sex or hormonal status in human and non-human primates? Horm Behav (2009) 1.37
Reducing hospital presentations for opioid overdose in patients treated with sustained release naltrexone implants. Drug Alcohol Depend (2005) 1.33
Effects of oral THC maintenance on smoked marijuana self-administration. Drug Alcohol Depend (2002) 1.24
Nefazodone decreases anxiety during marijuana withdrawal in humans. Psychopharmacology (Berl) (2002) 1.22
Reinforcing effects of oral Delta9-THC in male marijuana smokers in a laboratory choice procedure. Psychopharmacology (Berl) (2005) 1.18
Effects of baclofen on cocaine self-administration: opioid- and nonopioid-dependent volunteers. Neuropsychopharmacology (2006) 1.16
Depot naltrexone: antagonism of the reinforcing, subjective, and physiological effects of heroin. Psychopharmacology (Berl) (2006) 1.16
Dronabinol and marijuana in HIV(+) marijuana smokers: acute effects on caloric intake and mood. Psychopharmacology (Berl) (2005) 1.13
Neurophysiological and cognitive effects of smoked marijuana in frequent users. Pharmacol Biochem Behav (2010) 1.13
Comparison of the analgesic effects of dronabinol and smoked marijuana in daily marijuana smokers. Neuropsychopharmacology (2013) 1.13
Management of relapse in naltrexone maintenance for heroin dependence. Drug Alcohol Depend (2007) 1.11
Interaction between naltrexone and oral THC in heavy marijuana smokers. Psychopharmacology (Berl) (2002) 1.10
Deficits in dopamine D(2) receptors and presynaptic dopamine in heroin dependence: commonalities and differences with other types of addiction. Biol Psychiatry (2011) 1.10
Intranasal cocaine in humans: effects of sex and menstrual cycle. Pharmacol Biochem Behav (2006) 1.09
Attentional bias towards cocaine-related stimuli: relationship to treatment-seeking for cocaine dependence. Am J Drug Alcohol Abuse (2007) 1.09
Opioid maintenance treatment as a harm reduction tool for opioid-dependent individuals in New York City: the need to expand access to buprenorphine/naloxone in marginalized populations. J Addict Dis (2012) 1.08
Sex differences and hormonal influences on response to cold pressor pain in humans. J Pain (2006) 1.08
Response to cocaine, alone and in combination with methylphenidate, in cocaine abusers with ADHD. Drug Alcohol Depend (2005) 1.08
Residual effects of intranasal methamphetamine on sleep, mood, and performance. Drug Alcohol Depend (2007) 1.07
Nabilone decreases marijuana withdrawal and a laboratory measure of marijuana relapse. Neuropsychopharmacology (2013) 1.06
Training physicians to treat substance use disorders. Curr Psychiatry Rep (2008) 1.06
A direct comparison of the behavioral and physiological effects of methamphetamine and 3,4-methylenedioxymethamphetamine (MDMA) in humans. Psychopharmacology (Berl) (2011) 1.06
Effects of baclofen and mirtazapine on a laboratory model of marijuana withdrawal and relapse. Psychopharmacology (Berl) (2010) 1.06
Predictors of marijuana relapse in the human laboratory: robust impact of tobacco cigarette smoking status. Biol Psychiatry (2012) 1.05
Aripiprazole maintenance increases smoked cocaine self-administration in humans. Psychopharmacology (Berl) (2011) 1.04
Acute effects of smoked marijuana on decision making, as assessed by a modified gambling task, in experienced marijuana users. J Clin Exp Neuropsychol (2007) 1.03
Relationship between rate of infusion and reinforcing strength of oxycodone in humans. J Opioid Manag (2009) 1.03
Modafinil does not serve as a reinforcer in cocaine abusers. Drug Alcohol Depend (2009) 1.02
Dopamine D1 receptors in cocaine dependence measured with PET and the choice to self-administer cocaine. Neuropsychopharmacology (2009) 1.02
Comparison of intranasal methamphetamine and d-amphetamine self-administration by humans. Addiction (2012) 1.00
Research design considerations for clinical studies of abuse-deterrent opioid analgesics: IMMPACT recommendations. Pain (2012) 0.99
Long-acting injectable versus oral naltrexone maintenance therapy with psychosocial intervention for heroin dependence: a quasi-experiment. J Clin Psychiatry (2010) 0.99
Gabapentin maintenance decreases smoked cocaine-related subjective effects, but not self-administration by humans. Drug Alcohol Depend (2004) 0.98
Effects of the NMDA antagonist memantine on human methamphetamine discrimination. Psychopharmacology (Berl) (2002) 0.98
Cardiovascular and subjective effects of repeated smoked cocaine administration in experienced cocaine users. Drug Alcohol Depend (2009) 0.98
Using a novel alternative to drug choice in a human laboratory model of a cocaine binge: a game of chance. Drug Alcohol Depend (2010) 0.97
The effects of oral micronized progesterone on smoked cocaine self-administration in women. Horm Behav (2010) 0.97
Effects of acute oral naltrexone on the subjective and physiological effects of oral D-amphetamine and smoked cocaine in cocaine abusers. Neuropsychopharmacology (2013) 0.97
Decision-making in long-term cocaine users: Effects of a cash monetary contingency on Gambling task performance. Drug Alcohol Depend (2009) 0.96
Efficacy and tolerability of high-dose dronabinol maintenance in HIV-positive marijuana smokers: a controlled laboratory study. Psychopharmacology (Berl) (2010) 0.96
Betting on change: modeling transitional probabilities to guide therapy development for opioid dependence. Psychol Addict Behav (2009) 0.96
Risks, management, and monitoring of combination opioid, benzodiazepines, and/or alcohol use. Postgrad Med (2013) 0.95
Core outcome measures for opioid abuse liability laboratory assessment studies in humans: IMMPACT recommendations. Pain (2012) 0.95
A human laboratory study investigating the effects of quetiapine on marijuana withdrawal and relapse in daily marijuana smokers. Addict Biol (2012) 0.94
Smoked cocaine discrimination in humans: effects of gabapentin. Drug Alcohol Depend (2005) 0.94
Modafinil attenuates disruptions in cognitive performance during simulated night-shift work. Neuropsychopharmacology (2005) 0.93
Acute and residual interactive effects of repeated administrations of oral methamphetamine and alcohol in humans. Psychopharmacology (Berl) (2011) 0.92
Non-medical use of opioids among HIV-infected opioid dependent individuals on opioid maintenance treatment: the need for a more comprehensive approach. Harm Reduct J (2011) 0.92
Naltrexone treatment for opioid dependence: does its effectiveness depend on testing the blockade? Drug Alcohol Depend (2013) 0.92
Dextromethorphan and quinidine combination for heroin detoxification. Am J Addict (2008) 0.92
Exercise "addiction" in anorexia nervosa: model development and pilot data. CNS Spectr (2004) 0.92
Combined effects of methamphetamine and zolpidem on performance and mood during simulated night shift work. Pharmacol Biochem Behav (2005) 0.91
Sex differences and hormonal influences on response to mechanical pressure pain in humans. J Pain (2009) 0.91
Behavioral assessment of the reinforcing effect of exercise in women with anorexia nervosa: further paradigm development and data. Int J Eat Disord (2010) 0.90
A comparison among tapentadol tamper-resistant formulations (TRF) and OxyContin® (non-TRF) in prescription opioid abusers. Addiction (2013) 0.90
Pharmacokinetics of intravenous cocaine across the menstrual cycle in rhesus monkeys. Neuropsychopharmacology (2004) 0.90
Relative reinforcing value of exercise in inpatients with anorexia nervosa: model development and pilot data. Int J Eat Disord (2007) 0.89
Gabapentin does not reduce smoked cocaine self-administration: employment of a novel self-administration procedure. Behav Pharmacol (2007) 0.88
The subjective, reinforcing, and analgesic effects of oxycodone in patients with chronic, non-malignant pain who are maintained on sublingual buprenorphine/naloxone. Neuropsychopharmacology (2010) 0.88
The effects of acute pretreatment with high-dose memantine on the cardiovascular and behavioral effects of cocaine in humans. Exp Clin Psychopharmacol (2007) 0.88